Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 1/20 | 0.61 |
| ▸ | ESR1 | P03372 | 1/20 | 0.53 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | CES2 | O00748 | 2/20 | 0.48 |
| ▸ | CES1 | P23141 | 2/20 | 0.48 |
| ▸ | BCHE | P06276 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.48 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.46 |
| ▸ | MYC | P01106 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.44 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.44 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29570483 | 1.00 | ALB (0.61) | ALBESR1ESR2TSHRALDH1A1 | |
| SCHEMBL27703149 | 0.84 | TSHR (0.61) | TSHRALDH1A1KDM4EHSD17B10HPGD | |
| Benzene SCHEMBL27265959 | 0.84 | TSHR (0.61) | TSHRALDH1A1KDM4EHSD17B10HPGD | |
| SCHEMBL756585 | 0.84 | TSHR (0.61) | TSHRALDH1A1KDM4EHSD17B10HPGD | |
| SCHEMBL25198802 | 0.83 | ALB (0.45) | ALBESR1ESR2TSHRALDH1A1 | |
| SCHEMBL11476967 | 0.83 | ESR1 (0.53) | ALBESR1ESR2ALDH1A1HPGD | |
| SCHEMBL4451884 | 0.83 | ESR1 (0.53) | ALBESR1ESR2ALDH1A1KDM4E | |
| SCHEMBL17040388 | 0.83 | ESR1 (0.53) | ALBESR1ESR2ALDH1A1HSD17B10 | |
| SCHEMBL27479457 | 0.81 | TSHR (0.59) | TSHRALDH1A1KDM4EHSD17B10HPGD | |
| SCHEMBL10768142 | 0.81 | TSHR (0.59) | TSHRALDH1A1KDM4EHSD17B10HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 539 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117024342-B | Synthesis method of phenanthridine OLED material | 上海海皋科技有限公司 | 2024-11-08 | — | — | CN | claimed |
| CN-118206444-A | Synthesis method of 6-bromo-3-fluoro-2-methylbenzoic acid | 上海毕得医药科技股份有限公司 | 2024-06-18 | — | — | CN | claimed |
| CN-117024342-A | Synthesis method of phenanthridine OLED material | 上海海皋科技有限公司 | 2023-11-10 | — | — | CN | claimed |
| CN-116836081-A | Ether epoxy toughening agent and preparation method and application thereof | 中国林业科学研究院林产化学工业研究所 | 2023-10-03 | — | — | CN | claimed |
| CN-116375734-A | Ballon Sha Weizhi isomer and preparation method thereof | 思科(深圳)药物研发有限公司 | 2023-07-04 | — | — | CN | claimed |
| CN-109212056-B | Gas chromatography-mass spectrometry combined method for determining three trace monohalogenated methylbenzoic acids in water source water | 丁立平 | 2021-05-07 | — | — | CN | claimed |
| CN-110357850-A | A kind of preparation method of sulfur heterocyclic compound | 广东东阳光药业有限公司 | 2019-10-22 | — | — | CN | claimed |
| CN-110204433-A | The synthetic method of the fluoro- 2- methyl benzoic acid of 3,4- of one kind bis- | 湖南师范大学 | 2019-09-06 | — | — | CN | claimed |
| CN-110088108-A | SUBSTITUTED PYRAZOLOAZEPIN-4-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS | 利奥制药有限公司 | 2019-08-02 | — | — | CN | claimed |
| US-10072043-B2 | Inhibitors of protein tyrosine phosphatases | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2018-09-11 | — | — | US | claimed |
| US-20120088720-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATI (US) | 2012-04-12 | — | — | US | claimed |
| WO-2010118241-A2 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION (US) | 2010-10-14 | — | — | WO | claimed |
| US-7732625-B2 | Colorant compounds | XEROX CORPORATION (US) | 2010-06-08 | — | — | US | claimed |
| US-7311767-B2 | Forming a salt of a liquid phase change ink carrier of stearyl stearamide, an amine substituted Xanthene, acridine, anthracene or thioxanthene chromogen, and a metal salt capable of forming a compound with two chromogens | XEROX CORPORATION (US) | 2007-12-25 | — | — | US | claimed |
| US-7033424-B2 | Phase change inks | XEROX CORPORATION (US) | 2006-04-25 | — | — | US | claimed |
| US-20060021546-A1 | Processes for preparing phase change inks | XEROX CORPORATION | 2006-02-02 | — | — | US | claimed |
| US-20060020141-A1 | Metallized dye | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20060016369-A1 | PHASE CHANGE INKS | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-6946025-B2 | Process for preparing tetra-amide compounds | XEROX CORPORATION (US) | 2005-09-20 | — | — | US | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10072043-B2 | Inhibitors of protein tyrosine phosphatases | PTPRCAP, PTPRF, PTPRS | ALB 2723/4885ESR1 4599/4885ESR2 4600/4885 |
| US-20060020141-A1 | Metallized dye | CDYL, CDY1; CDY1B, CDYL2 | ALB 1055/4885ESR1 1511/4885ESR2 1600/4885 |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | ALB 137/4885ESR1 4582/4885ESR2 4815/4885 |
| US-20120088720-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | PTPRCAP, PTPRF, PTPRS | ALB 2723/4885ESR1 4599/4885ESR2 4600/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.